Clinical Trial Update: Superselective Citicoline and Verapamil for Ischemic Neuroprotection and Greater Effective Response [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating superselective citicoline with verapamil for ischemic stroke was withdrawn from the study registry, with the trial status mark…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Superselective Citicoline (citicoline (CDP-choline))
• Verapamil (verapamil)

Snippet

Sponsor: Justin Fraser | Conditions: Ischemic Stroke | Phase 1 | Status: WITHDRAWN